ReviewAntioxidants (Basel, Switzerland)2026
Nanoantioxidants: Structure-Activity Relationships, Redox Mechanisms, Applications, and Safety.
Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Oxidative stress contributes to disease progression, food deterioration, agricultural losses, and material degradation, whereas many conventional antioxidants are limited by poor stability, low bioavailability, rapid consumption, or inadequate delivery. In this review, nanoantioxidants are defined as nanoscale systems intentionally designed to suppress or regulate damaging oxidative processes, and four functional categories are distinguished: intrinsically antioxidant nanomaterials, antioxidant nanozymes, antioxidant-functionalized nanoparticles, and nanocarriers used to deliver conventional antioxidants. The review systematically examines how particle size and surface area, morphology and exposed facets, oxidation state and defect density, surface chemistry and charge, aggregation, dissolution or ion release, dose, and the surrounding environment determine antioxidant activity. Particular emphasis is placed on the context-dependent transition from antioxidant to pro-oxidant behavior, the distinction between enzyme-like nanozyme activity and true enzymatic activity, and the need for nanoparticle-specific controls and complementary assays to avoid analytical interference. Evidence from chemical assays, cell culture, animal studies, and clinical research is considered separately because activity in a simplified chemical system does not by itself establish therapeutic efficacy or safety. Applications in nanomedicine, food preservation, agriculture, environmental protection, and engineering materials are critically compared. Long-term toxicity, biodistribution, clearance, degradation, environmental fate, and life-cycle impacts are highlighted as essential translational criteria; likewise, green synthesis is not treated as synonymous with sustainability without consideration of energy, solvents, purification, scalability, waste, and end-of-life behavior. Future progress will require standardized datasets and experimental protocols, mechanism-guided design, realistic validation, and carefully governed artificial-intelligence-assisted optimization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.